In Brief: CellPro/Corange
Executive Summary
CellPro/Corange: Agree to end the CEPRATE collaboration begun in December 1993, Bothell, Wash.-based CellPro announces. Corange will return all rights to CellPro property, with the companies exchanging releases in settlement of all previous claims. Corange also will pay CellPro $30 mil. for rights of supply and 1 mil. new shares of CellPro common stock. Cellpro will support Corange in the development and worldwide commercialization of gene medicine by non-exclusively supplying the company with CEPRATE cell separation systems...